Results 51 to 60 of about 4,431,933 (293)

Current understanding of primary biliary cholangitis [PDF]

open access: yesClinical and Molecular Hepatology, 2021
Primary biliary cholangitis (PBC) causes chronic and persistent cholestasis in the liver, eventually resulting in cirrhosis and hepatic failure without appropriate treatment.
Atsushi Tanaka
doaj   +1 more source

Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

open access: yesHepatology, 2018
This American Association for the Study of Liver Diseases (AASLD) 2018 Practice Guidance on Primary Biliary Cholangitis (PBC) is an update of the PBC guidelines published in 2009.
K. Lindor   +4 more
semanticscholar   +1 more source

An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

open access: yesJournal of Hepatology, 2021
Backgrounds & Aims Primary biliary cholangitis (PBC) is a chronic liver disease in which autoimmune destruction of the small intrahepatic bile ducts eventually leads to cirrhosis. Many patients have inadequate response to licensed medications, motivating
H. Cordell   +42 more
semanticscholar   +1 more source

Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection [PDF]

open access: yes, 2016
Christopher L Bowlus Division of Gastroenterology and Hepatology, University of California Davis, Davis, CA, USA Abstract: Primary biliary cholangitis (PBC), previously known as primary biliary “cirrhosis”, is a rare autoimmune liver disease ...
Bowlus CL, Bowlus, Christopher L
core   +1 more source

GLIMMER: A randomized Phase 2b dose-ranging trial of linerixibat in primary biliary cholangitis patients with pruritus.

open access: yesClinical Gastroenterology and Hepatology, 2022
BACKGROUND AND AIMS GLIMMER assessed dose-response, efficacy, and safety of linerixibat, an ileal bile acid transporter inhibitor in development for cholestatic pruritus associated with primary biliary cholangitis (PBC). METHODS GLIMMER was a Phase 2b,
C. Levy   +12 more
semanticscholar   +1 more source

Role of autoantibodies in the clinical management of primary biliary cholangitis

open access: yesWorld Journal of Gastroenterology, 2023
Primary biliary cholangitis (PBC) is a chronic cholestatic liver disease characterized by immune-driven destruction of small intrahepatic bile ducts leading a proportion of patients to hepatic failure over the years.
E. Rigopoulou, Dimitrios-Petrou Bogdanos
semanticscholar   +1 more source

Medical Management of Chronic Cholestatic Liver Diseases

open access: yesCanadian Journal of Gastroenterology, 2000
The purpose of the present review is to discuss the diagnosis and management of cholestatic liver diseases. Differential diagnoses to consider are described, including causes of extrahepatic biliary obstruction such as gallstones, strictures ...
Andrea A Gossard, Keith D Lindor
doaj   +1 more source

Primary biliary cirrhosis and autoimmune cholangitis are not associated with coeliac disease in Crete

open access: yesBMC Gastroenterology, 2002
Background An increased prevalence of coeliac disease in patients with primary biliary cirrhosis has been recently reported. However, in other studies the association has not been confirmed.
Dimoulios Philippos   +8 more
doaj   +1 more source

Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis

open access: yesThe Korean Journal of Gastroenterology, 2020
Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are immune-mediated chronic liver diseases. PSC is a rare disorder characterized by multi-focal bile duct strictures and progressive liver diseases that ultimately results in the ...
Dong-Won Ahn
doaj   +1 more source

Preventative care in cholestatic liver disease: Pearls for the specialist and subspecialist

open access: yesLiver Research, 2019
Cholestatic liver diseases (CLDs) encompass a variety of disorders of abnormal bile formation and/or flow. CLDs often lead to progressive hepatic insult and injury and following the development of cirrhosis and associated complications.
Adnan Malik   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy